Documente Academic
Documente Profesional
Documente Cultură
de management al infecțiilor
asociate îngrijirilor de sănătate – un
punct de vedere
A Acinetobacter baumannii
P Pseudomonas aeruginosa
Enterobacteriaceae includ
E Enterobacteriaceae K. pneumoniae, Enterobacter
spp., si alte specii rezistente ca
Escherichia coli si Proteus spp.
16
Scorul Carmeli Bacterii și Fungi
?,(2#\.(1&(%#)-&.`##,01%
Germeni MRSA
cu sensibilitate G-neg MDR:
+
la AB G-neg/poz non-fermentativi:
posisbil p"strat" posibil -!piocianic
MDR ± ESBL -!acinetobacter
Evaluarea riscului - Carmeli
A. Contactul cu sectorul sanitar:
1) Fără contact 1
2) Contact fără proceduri invazive 2
3) Contacte repetate cu proceduri invazive 3
B. Tratament AB:
1
1) Fără AB
2
2) Cu AB în antecedente
C. CaracterisNcile pacientului:
1) Tânăr – fără comorbidităţi 1
!!##<=T2#0%#$&"-'9#
!!##7,%+.C)C)+9# !!##7,%+.C)C)+9#=#9'#7# !!##5#!6%('7,%$*(!
!!!!"#$%&'(%)*(! !!!!"#$%&#!Y#$%)(%-C(! !!!!2)",%-CQ')-%(#$&&B#
!!!!+,-*.(//*!0*12*-*/$3! !!!!+#!4*12*-*/$3!=#9'#7# !!##7"C)"',")#
!!##<=T2#)C.+,"-'(# !!##Z%(.%,"#<4=##
!!##Z%(.%,"#0%#$&"-'9#
7(CQ9%.%#&C-%,R"'9%# 7(CQ9%.%#
7(CQ9%.%#&C-%,R"'9%#
&%,-(+#2LM# &C-%,R"'9%#
&%,-(+#2LM#
&%,-(+#2LM#
Infecţii Infecţii
asociate nosocomiale
Infecţii îngrijirilor
comunitare medicale
Imipenem/Meropenem
Ertapenem Aminoglicozide
Aminoglicozide
FQ GIV – Moxi iv
Ampicilină ±FQ – Levo/Moxi po/i.v.
CGIII/IV CGIII antiPS
Amoxi/clav
C-antiPs. CGIV:
FQ – Levo/Moxi po
CGII/III βlactami+I.β lactamaze • Cefepim,
Macrolide (Amoxi/clav SR, ES) • Cefpirom
Linezolid/Vancomicină Linezolid / Vancomicină
Macrolide Macrolide
?8'9+'(%'#("$)+9+"#A'(.%9"@9"[%#
2B#AC,-',)-#)+#$%)-C(+9#$',"-'(D#
EF! G*(*#)C,-')-# 1
HF! AC,-')-#I*(*#&(C)%0+("#",8'J"8%# 2
KF! AC,-')-%#I(%)8%,-%#)+#&(C)%0+("#",8'J"8%# 3
LB#M%('&"%#)+#2L#\"#2GD#
EF! G*(*#2L#\"X$'+#2G# 1
HF! A+#2L#\"X$'+#2G#(%)%,-%#)+#'JC9"# 2
AB#A'(')-%("$N)"9%#&')"%,-+9+"D#
EF! MO,*(#P#I*(*##)C@.C(Q"0"-*R"# 1
HF! !O($-,")#P#)+##)C@.C(Q"0"-*R"# 2
KF! S.+,C)C.&(C."$D##
"! 2S4T# 3
"! L7UA#
"! A',)%(#
"! L<M#
Score : 1, 2 or 3
Terapia Infectiilor fungice invazive
IFI IFI
asociate Nosocomiale
IFI
îngrijirilor
comunitare de s"n"tate
Neutropenic:
Caspo (AI) Caspofungin
Anidula (AI)
Mica (AI)
Voriconazol
Fluconazol Voriconazol
Itraconazol Posaconazol
Posaconazol
AMB Non-neutropenic:
Caspofungin
Anidulafungin
Micafungin
Fluconazol
Voriconazol
Itraconazol Posaconazol
Pacientul TI
±Sepsis Soc
Sepsis Sever
septic
Non-neutropenic F0 Neutropenic F0
+ factt de risc
PMN<1000/mm3
AB + AF cu
PCT spectru ultralarg 72h
Dezescaladare
<1 >1 Completa*
1,3-!-D-glucans 1,3-!-D-glucans
Neg Poz
AB AB + AF
Sugestii în vederea ini#ierii TAF în TI – de la practica curent" la ghiduri
2013
G')]B#0%#("$)#&-B# G')-B#0%#("$)#&-B%
2$&B#T&&# A',0"0'#$&&B#
A'(.%9"P9"[%#E#X#H#
G*(*#'JC9"#',-%("C(#
!U=#^2SF#X#AT7#^ASSSF# G*(*#0'-%#9C)'9%# A'(.%9"#P9"[%#H#$'+#K#
?e&+,%(%#9'#'JC9#
%&"0%."C9C_")%#0%##
4'-%#9C)'9%#%&"0%."C9C_"%##
AB#,C,@'9Q")',$#
0%#=#9'#G9+)C,'JC9#'#AB#'9Q")',$X#
,C,@'9Q")',$#
Neutropenic
A'(.%9"@9"[%#E# A'(.%9"@9"[%#H## b0)>b&7+108&)#.%
S,I%)R""#'$C)"'-%#
G*(*#)C,-')-#)+# AT7#^2SF#
:,_("d"("9C(#0%#
$%)-C(+9#$',"-'(# AT7#X#2V4#X#<SA2#X#!U=``##
$*,*-'-%# !U=#^LSF#
2GLaA#^LSF#
<SA2^LSSF#
GaW#bcc._XJ"# •!AT7##
•!2V4#
•!<SA2#
•!!U=#
•!7UT`#
20%(%,R'#
c%
T)C(#0%#'_(%$"8"-'-%#
c# <TT2#
L"C/9.#
AC(%9'R"%D#T)C(+9#0%#'_(%$"8"-'-%#'#
$-'/9C)C)+9+"#@#T)C(+9#A'(.%9"#
T)C(#0%#'_(%$"8"-'-%#
K# <=T2# MX!Xa# K#
T)C(+9#A'(.%9"#
H# <=T2 <TT2 MX!Xa Ue'
H#
E# <=T2 <TT2 MX!Xa Ue'
c# <TT2# Ue'# E#
dJ%d&#.08,()#)B%VJV().0'#.#)5B%eJe#)&S0,#$B%T_(J%T_(.#,#)5%
<','_%.%,-+9#)'-%-%(+9+"#8%,C$#
)%,-('9#
T)C(#0%#'_(%$"8"-'-%#
<','_%.%,-+9#A!A#
K# <=T2# l,9C)+"(%'#A!A#
<%,R",%(%'#A!A##
E# <=T2 <TT2 :,#I+,)R"%#0%#
(%J+9-'-+9#79%eS4#
<%,R",%(%'#A!A##
c# <TT2# :,#I+,)R"%#0%#
(%J+9-'-+9#79%eS4#
Cam așa ceva...